What is the current price of ABT.SW?

The current price of Abbott Laboratories on the Swiss Exchange is CHF 99.0, experiencing a 1.98% drop recently. This move has put the stock in oversold territory.

What does Meyka AI's forecast say about Abbott's future price?

Meyka AI's forecast projects that ABT.SW could reach CHF 108.2 in the next quarter, reflecting a potential upside of 9.29% from the current price. Forecasts are model-based projections and not guarantees.

Is Abbott Laboratories considered a buy at the current price?

Meyka AI rates ABT.SW with an 'A' grade and a 'BUY' recommendation based on analysis across multiple factors, suggesting it could be a beneficial addition to portfolios.

How does the recent price change affect investors?

The recent decline may offer a buying opportunity as the stock appears oversold, potentially setting the stage for a rebound. Investors should consider this alongside other financial metrics.

What influenced the recent price drop in Abbott Laboratories stock?

The watchful market reaction to earnings results, which fell short of estimates, primarily influenced the recent decline. This, coupled with market volatility, contributed to the drop.

CH Stocks

ABT.SW Pre-Market (21 Dec 2025): Oversold Conditions Hint at Rebound

ByHuzaifa Zahoor December 21, 2025December 21, 2025

Abbott Laboratories (ABT.SW) recently fell by 1.98%, closing at CHF 99.0 on the Swiss Exchange (SIX). This decline places the stock into oversold territory, presenting a potential rebound opportunity. This analysis explores key metrics, technical indicators, and market sentiment driving the current price action.